NeuroBo is a clinical-stage biopharmaceutical company with two drug programs that hope to impact a range of indications in neurodegenerative disease. NeuroBo Pharmaceuticals is addressing unmet needs in patients with diabetic neuropathy and Alzheimer’s disease. Our Phase III-ready drug, NB-01, is based on natural sources and has shown successful Phase II results with excellent efficacy and safety in diabetic neuropathic pain...
NeuroBo is a clinical-stage biopharmaceutical company with two drug programs that hope to impact a range of indications in neurodegenerative disease. NeuroBo Pharmaceuticals is addressing unmet needs in patients with diabetic neuropathy and Alzheimer’s disease. Our Phase III-ready drug, NB-01, is based on natural sources and has shown successful Phase II results with excellent efficacy and safety in diabetic neuropathic pain (DNP) and we have strong preclinical data in both neuropathic pain and diabetes models showing a mode of action of NB-01 on nerve growth factor (NGF) release for nerve stabilization and regeneration.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.